Pasar al contenido principal

ENTENDIENDO EL PAPEL DE LA COMUNICACION CELULAR EN EL SISTEMA INMUNE EN LA DESREGULACION EPIGENETICA EN INFLAMACION

PID2020-117212RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation

  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Calafell-Segura, Josep|||0000-0002-0173-8221
  • Calvillo, Celia L.
  • Keller, Baerbel
  • Ciudad, Laura|||0000-0002-5219-6792
  • Handfield, Louis-François
  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Andrés-León, Eduardo|||0000-0002-0621-9914
  • Hoo, Regina
  • Porter, Tarryn|||0000-0002-6063-0659
  • Prigmore, Elena|||0000-0001-8870-0316
  • Hofmann, Maike|||0000-0001-8410-8833
  • Decker, Annegrit
  • Martín, Javier|||0000-0002-2202-0622
  • Vento Tormo, Roser|||0000-0002-9870-8474
  • Warnatz, Klaus|||0000-0002-1172-865X
  • Ballestar, Esteban|||0000-0002-1400-2440
Common variable immunodeficiency (CVID) is the most prevalent primary immunodeficiency, marked by hypogammaglobulinemia, poor antibody responses, and increased infection susceptibility. The COVID-19 pandemic provided a unique opportunity to study the effects of prolonged viral infections on the immune responses of CVID patients. Here we use single-cell RNA-seq and spectral flow cytometry of peripheral blood samples before, during, and after SARS-CoV-2 infection showing that COVID-19 CVID patients display a persistent type I interferon signature at convalescence across immune compartments. Alterations in adaptive immunity include sustained activation of naïve B cells, increased CD21 B cells, impaired Th1 polarization, CD4 T central memory exhaustion, and increased CD8 T cell cytotoxicity. NK cell differentiation is defective, although cytotoxicity remains intact. Monocytes show persistent activation of inflammasome-related genes. These findings suggest the involvement of intact humoral immunity in regulating these processes and might indicate the need for early intervention to manage viral infections in CVID patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis

  • Fondelli, Federico|||0000-0002-6875-4744
  • Willemyns, Jana|||0000-0001-6325-9309
  • Domenech-Garcia, Roger|||0009-0002-5742-566X
  • Mansilla, Maria José
  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Ferreté-Bonastre, Anna G.|||0000-0003-3327-6129
  • Agúndez-Moreno, Alex|||0009-0000-9524-235X
  • Presas Rodríguez, Sílvia|||0000-0001-8545-2476
  • Ramo-Tello, Cristina|||0000-0001-8643-5053
  • Ballestar, Esteban|||0000-0002-1400-2440
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
Multiple sclerosis (MS) is a chronic disease characterized by dysregulated self-reactive immune responses that damage the neurons' myelin sheath, leading to progressive disability. The primary therapeutic option, immunosuppressants, inhibits pathogenic anti-myelin responses but depresses the immune system. Antigen-specific monocyte-derived autologous tolerogenic dendritic cells (tolDCs) offer alternative therapeutic approaches to restore tolerance to autoantigens without causing generalized immunosuppression. However, immune dysregulation in MS could impact the properties of the monocytes used as starting material for this cell therapy. Here, we characterized CD14+ monocytes, mature dendritic cells, and vitamin D3-tolDCs (VitD3-tolDCs) from active, treatment-naive MS patients and healthy donors (HDs). Using multiomics, we identified a switch in these cell types toward proinflammatory features characterized by alterations in the aryl hydrocarbon receptor (AhR) and NF-κB pathways. MS patient-derived VitD3-tolDCs showed reduced tolerogenic properties compared with those from HDs, which were fully restored through direct AhR agonism and by use of in vivo or in vitro dimethyl fumarate (DMF) supplementation. Additionally, in the experimental autoimmune encephalomyelitis mouse model, combined therapy of DMF and VitD3-tolDCs was more efficient than monotherapies in reducing the clinical score of mice. We propose that a combined therapy with DMF and VitD3-tolDCs offers enhanced therapeutic potential in treating MS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment

  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Calafell-Segura, Josep|||0000-0002-0173-8221
  • Gardet, M.
  • Dunsmore, G.
  • Mulder, K.
  • Ciudad, Laura|||0000-0002-5219-6792
  • Silvin, A.
  • Moreno-Càceres, Joaquim|||0000-0002-4166-9419
  • Corbí, Á.L.
  • Muñoz-Pinedo, Cristina|||0000-0002-9120-664X
  • Michels, J.
  • Gouy, S.
  • Dutertre, C.A.
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ginhoux, F.
  • Ballestar, Esteban|||0000-0002-1400-2440
Macrophages orchestrate tissue homeostasis and immunity. In the tumor microenvironment (TME), macrophage presence is largely associated with poor prognosis because of their reprogramming into immunosuppressive cells. We investigated the effects of hypoxia, a TME-associated feature, on the functional, epigenetic, and transcriptional reprogramming of macrophages and found that hypoxia boosts their immunogenicity. Hypoxic inflammatory macrophages are characterized by a cluster of proinflammatory genes undergoing ten-eleven translocation-mediated DNA demethylation and overexpression. These genes are regulated by NF-κB, while HIF1α dominates the transcriptional reprogramming, demonstrated through ChIP-seq and pharmacological inhibition. In bladder and ovarian carcinomas, hypoxic inflammatory macrophages are enriched in immune-infiltrated tumors, correlating with better patient prognoses. Coculture assays and cell-cell communication analyses support that hypoxic-activated macrophages enhance T cell-mediated responses. The NF-κB-associated hypomethylation signature is displayed by a subset of hypoxic inflammatory macrophages, isolated from ovarian tumors. Our results challenge paradigms regarding the effects of hypoxia on macrophages and highlight actionable target cells to modulate anticancer immune responses.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Purinergic exposure induces epigenomic and transcriptomic-mediated preconditioning resembling epilepsy-associated microglial states

  • Martins-Ferreira, Ricardo
  • Calafell-Segura, Josep|||0000-0002-0173-8221
  • Chaves, João
  • Ciudad, Laura|||0000-0002-5219-6792
  • Martins da Silva, António
  • Pinho e Costa, Paulo
  • Leal, Bárbara
  • Ballestar, Esteban|||0000-0002-1400-2440
Microglia play a crucial role in a range of neuropathologies through exacerbated activation. Microglial inflammatory responses can be influenced by prior exposures to noxious stimuli, like increased levels of extracellular adenosine and ATP. These are characteristic of brain insults like epileptic seizures and could potentially shape subsequent responses through epigenetic regulation. We investigated DNA methylation and expression changes in human microglia-like cells differentiated from monocytes following ATP-mediated preconditioning. We demonstrate that microglia-like cells display homeostatic microglial features, shown by surface markers, transcriptome, and DNA methylome. After exposure to ATP, TLR-mediated activation leads to an exacerbated pro-inflammatory response. These changes are accompanied by methylation and transcriptional reprogramming associated with enhanced immune-related functions. The reprogramming associated with ATP-mediated preconditioning leads to profiles found in microglial subsets linked to epilepsy. Purine-driven microglia immune preconditioning drives epigenetic and transcriptional changes that could contribute to altered functions of microglia during seizure development and progression.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection

  • Barmada, Anis
  • Marchese, Domenica, 1986-
  • Heyn, Holger
  • Rodríguez Ubreva, Javier
In COVID-19, hyperinflammatory and dysregulated immune responses contribute to severity. Patients with pre-existing autoimmune conditions can therefore be at increased risk of severe COVID-19 and/or associated sequelae, yet SARS-CoV-2 infection in this group has been little studied. Here, we performed single-cell analysis of peripheral blood mononuclear cells from patients with three major autoimmune diseases (rheumatoid arthritis, psoriasis, or multiple sclerosis) during SARS-CoV-2 infection. We observed compositional differences between the autoimmune disease groups coupled with altered patterns of gene expression, transcription factor activity, and cell-cell communication that substantially shape the immune response under SARS-CoV-2 infection. While enrichment of HLA-DRlow CD14+ monocytes was observed in all three autoimmune disease groups, type-I interferon signaling as well as inflammatory T cell and monocyte responses varied widely between the three groups of patients. Our results reveal disturbed immune responses to SARS-CoV-2 in patients with pre-existing autoimmunity, highlighting important considerations for disease treatment and follow-up., This research was funded/supported by the R+D+i project of the Spanish Ministry of Science and Innovation (grant number PID2020-117212RB-I00/ MICIN/AEI/10.13039/501100011033), the Chan Zuckerberg Initiative (grant 2020–216799) and Wellcome Sanger core funding (WT206194). This publication has been supported by the Unstoppable campaign of the Josep Carreras Leukaemia Foundation. B.G., F.J.C.-N., and N.K.W. were funded by Wellcome (206328/Z/17/Z), the MRC (MR/S036113/1), and the Aging Biology Foundation.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

COVID-19 progression and convalescence in common variable immunodeficiency patients shows incomplete adaptive responses and persistent inflammasome activation

  • Rodríguez-Ubreva, Javier
  • Handfield, Louis-François
  • Keller, Baerbel
  • Ciudad, Laura
  • Calle-Fabregat, Carlos de la
  • Godoy-Tena, Gerard
  • Calafell-Segura, Josep
  • Andrés-León, Eduardo
  • Hoo, Regina
  • Porter, Tarryn
  • Prigmore, Elena
  • Hofmann, Maike
  • Decker, Annegrit
  • Martín, Javier
  • Klaus Warnatz
  • Vento-Tormo, Roser
  • Ballestar, Estéban
Patients with common variable immunodeficiency (CVID), the most prevalent symptomatic primary immunodeficiency, are characterized by hypogammaglobulinemia, poorly protective vaccine titers and increased susceptibility to infections. New pathogens such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), might constitute a particular threat to these immunocompromised patients since many of them experience a slower recovery and do not achieve full response to SARS-CoV-2 vaccines. To define the molecular basis of the altered immune responses caused by SARS-CoV-2 infection in CVID patients, we generated longitudinal single-cell datasets of peripheral blood immune cells along viral infection and recovery. We sampled the same individuals before, during and after SARS-CoV-2 infection to model their specific immune response dynamics while removing donor variability. We observed that COVID-19 CVID patients show defective canonical NF-κB pathway activation and dysregulated expression of BCR-related genes in naïve B cells, as well as enhanced cytotoxic activity but incomplete cytokine response in NK and T cells. Moreover, monocytes from COVID-19 CVID patients show persistent activation of several inflammasome-related genes, including the pyrin and NLRC4 inflammasomes. Our results shed light on the molecular basis of the prolonged clinical manifestations observed in these immunodeficient patients upon SARS-CoV-2 infection, which might illuminate the development of tailored treatments for COVID-19 CVID patients., We thank the CERCA Program/Generalitat de Catalunya and the Josep Carreras Foundation for institutional support. This publication is part of the Human Cell Atlas: www.humancellatlas.org/publications. This study was funded by ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420002, Spanish Ministry of Science and Innovation (grant number PID2020-117212RB-I00/AEI/10.13038/501100011033) (E.B.), by the Wellcome Trust Grant 206194 and 108413/A/15/D (R.V.-T.), Instituto de Salud Carlos III (ISCIII), Ref. AC18/00057, associated with i-PAD project (ERARE European Union program) (E.B.), and the Chan Zuckerberg Initiative (grant 2020-216799) (R.V.-T. and E.B.). This publication has also been supported by the Unstoppable campaign of the Josep Carreras Leukaemia Foundation. We are indebted to the donors for participating in this research., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection

  • Barmada, Anis
  • Handfield, Louis-François
  • Godoy-Tena, Gerard
  • Calle-Fabregat, Carlos de la
  • Ciudad, Laura
  • Arutyunyan, Anna
  • Andrés-León, Eduardo
  • Hoo, Regina
  • Porter, Tarryn
  • Ferrer, Ricard
  • Heyn, Holger
  • Prigmore, Elena
  • González-Álvaro, Isidoro
  • Martín, Javier
  • Ballestar, Estéban
  • Vento-Tormo, Roser
  • Rodríguez-Ubreva, Javier
Anis Barmada et al., In COVID-19, hyperinflammatory and dysregulated immune responses contribute to severity. Patients with pre-existing autoimmune conditions can therefore be at increased risk of severe COVID-19 and/or associated sequelae, yet SARS-CoV-2 infection in this group has been little studied. Here, we performed single-cell analysis of peripheral blood mononuclear cells from patients with three major autoimmune diseases (rheumatoid arthritis, psoriasis, or multiple sclerosis) during SARS-CoV-2 infection. We observed compositional differences between the autoimmune disease groups coupled with altered patterns of gene expression, transcription factor activity, and cell-cell communication that substantially shape the immune response under SARS-CoV-2 infection. While enrichment of HLA-DRlow CD14+ monocytes was observed in all three autoimmune disease groups, type-I interferon signaling as well as inflammatory T cell and monocyte responses varied widely between the three groups of patients. Our results reveal disturbed immune responses to SARS-CoV-2 in patients with pre-existing autoimmunity, highlighting important considerations for disease treatment and follow-up., This publication is part of the Human Cell Atlas (https://www.humancellatlas.org/publications/). The authors gratefully acknowledge the Sanger Cellular Genetics Informatics team, particularly A. Predeus and S. Murray for their assistance with aligning the published raw data from uninfected MS patients, as well as S. van Dongen, M. Prete, and Q. Lin for their help with online data hosting. We acknowledge the members of the Vento-Tormo and Ballestar groups for useful discussions. A.B. received additional support from a Gates Cambridge Scholarship. This research was funded/supported by the R+D+i project of the Spanish Ministry of Science and Innovation (grant number PID2020-117212RB-I00/ MICIN/AEI/10.13039/501100011033), the Chan Zuckerberg Initiative (grant 2020–216799) and Wellcome Sanger core funding (WT206194). This publication has been supported by the Unstoppable campaign of the Josep Carreras Leukaemia Foundation. B.G., F.J.C.-N., and N.K.W. were funded by Wellcome (206328/Z/17/Z), the MRC (MR/S036113/1), and the Aging Biology Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment

  • Calle-Fabregat, Carlos de la
  • Calafell-Segura, Josep
  • Gardet, Margaux
  • Dunsmore, Garett
  • Mulder, Kevin
  • Ciudad, Laura
  • Silvin, Aymeric
  • Moreno-Càceres, Joaquim
  • Corbí, Angel L.
  • Muñoz-Pinedo, Cristina
  • Michels, Judith
  • Gouy, Sébastien
  • Dutertre, Charles-Antoine
  • Rodríguez-Ubreva, Javier
  • Ginhoux, Florent
  • Ballestar, Estéban
16 p.-5 fig., Macrophages orchestrate tissue homeostasis and immunity. In the tumor microenvironment (TME), macrophage presence is largely associated with poor prognosis because of their reprogramming into immunosuppressive cells. We investigated the effects of hypoxia, a TME-associated feature, on the functional, epigenetic, and transcriptional reprogramming of macrophages and found that hypoxia boosts their immunogenicity. Hypoxic inflammatory macrophages are characterized by a cluster of proinflammatory genes undergoing ten-eleven translocation–mediated DNA demethylation and overexpression. These genes are regulated by NF-κB, while HIF1α dominates the transcriptional reprogramming, demonstrated through ChIP-seq and pharmacological inhibition. In bladder and ovarian carcinomas, hypoxic inflammatory macrophages are enriched in immune-infiltrated tumors, correlating with better patient prognoses. Coculture assays and cell-cell communication analyses support that hypoxic-activated macrophages enhance T cell–mediated responses. The NF-κB–associated hypomethylation signature is displayed by a subset of hypoxic inflammatory macrophages, isolated from ovarian tumors. Our results challenge paradigms regarding the effects of hypoxia on macrophages and highlight actionable target cells to modulate anticancer immune responses., This study was supported by the CERCA Programme/Generalitat de Catalunya and the Josep Carreras Foundation for institutional support. E.B. was funded by the Spanish Ministry of Science and Innovation (PID2020-117212RB-I00; AEI/10.13039/501100011033) and the Agency for Management of University and Research Grants (AGAUR; 2021 SGR 01213)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection

  • Barmada, Anis
  • Marchese, Domenica, 1986-
  • Heyn, Holger
  • Rodríguez Ubreva, Javier
In COVID-19, hyperinflammatory and dysregulated immune responses contribute to severity. Patients with pre-existing autoimmune conditions can therefore be at increased risk of severe COVID-19 and/or associated sequelae, yet SARS-CoV-2 infection in this group has been little studied. Here, we performed single-cell analysis of peripheral blood mononuclear cells from patients with three major autoimmune diseases (rheumatoid arthritis, psoriasis, or multiple sclerosis) during SARS-CoV-2 infection. We observed compositional differences between the autoimmune disease groups coupled with altered patterns of gene expression, transcription factor activity, and cell-cell communication that substantially shape the immune response under SARS-CoV-2 infection. While enrichment of HLA-DRlow CD14+ monocytes was observed in all three autoimmune disease groups, type-I interferon signaling as well as inflammatory T cell and monocyte responses varied widely between the three groups of patients. Our results reveal disturbed immune responses to SARS-CoV-2 in patients with pre-existing autoimmunity, highlighting important considerations for disease treatment and follow-up., This research was funded/supported by the R+D+i project of the Spanish Ministry of Science and Innovation (grant number PID2020-117212RB-I00/ MICIN/AEI/10.13039/501100011033), the Chan Zuckerberg Initiative (grant 2020–216799) and Wellcome Sanger core funding (WT206194). This publication has been supported by the Unstoppable campaign of the Josep Carreras Leukaemia Foundation. B.G., F.J.C.-N., and N.K.W. were funded by Wellcome (206328/Z/17/Z), the MRC (MR/S036113/1), and the Aging Biology Foundation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Vitamin C enhances NF-κB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells

  • Morante-Palacios, Octavio|||0000-0002-6435-2756
  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Calafell-Segura, Josep|||0000-0002-0173-8221
  • Ciudad, Laura|||0000-0002-5219-6792
  • Martínez-Cáceres, Eva M.
  • Sardina, José Luis|||0000-0002-8493-3937
  • Ballestar, Esteban|||0000-0002-1400-2440
Dendritic cells (DCs), the most potent antigen-presenting cells, are necessary for effective activation of naïve T cells. DCs' immunological properties are modulated in response to various stimuli. Active DNA demethylation is crucial for DC differentiation and function. Vitamin C, a known cofactor of ten-eleven translocation (TET) enzymes, drives active demethylation. Vitamin C has recently emerged as a promising adjuvant for several types of cancer; however, its effects on human immune cells are poorly understood. In this study, we investigate the epigenomic and transcriptomic reprogramming orchestrated by vitamin C in monocyte-derived DC differentiation and maturation. Vitamin C triggers extensive demethylation at NF-κB/p65 binding sites, together with concordant upregulation of antigen-presentation and immune response-related genes during DC maturation. p65 interacts with TET2 and mediates the aforementioned vitamin C-mediated changes, as demonstrated by pharmacological inhibition. Moreover, vitamin C increases TNFβ production in DCs through NF-κB, in concordance with the upregulation of its coding gene and the demethylation of adjacent CpGs. Finally, vitamin C enhances DC's ability to stimulate the proliferation of autologous antigen-specific T cells. We propose that vitamin C could potentially improve monocyte-derived DC-based cell therapies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines

  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Barmada, Anis
  • Morante-Palacios, Octavio|||0000-0002-6435-2756
  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Martins-Ferreira, Ricardo
  • Ferreté-Bonastre, Anna G.|||0000-0003-3327-6129
  • Ciudad, Laura|||0000-0002-5219-6792
  • Ruiz-Sanmartín, Adolfo|||0000-0001-5587-5419
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Ferrer, Ricard|||0000-0002-4859-4747
  • Ruiz-Rodriguez, Juan Carlos|||0000-0001-7392-8617
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Vento Tormo, Roser|||0000-0002-9870-8474
  • Ballestar, Esteban|||0000-0002-1400-2440
COVID-19 manifests with a wide spectrum of clinical phenotypes, ranging from asymptomatic and mild to severe and critical. Severe and critical COVID-19 patients are characterized by marked changes in the myeloid compartment, especially monocytes. However, little is known about the epigenetic alterations that occur in these cells during hyperinflammatory responses in severe COVID-19 patients. In this study, we obtained the DNA methylome and transcriptome of peripheral blood monocytes from severe COVID-19 patients. DNA samples extracted from CD14 + CD15- monocytes of 48 severe COVID-19 patients and 11 healthy controls were hybridized on MethylationEPIC BeadChip arrays. In parallel, single-cell transcriptomics of 10 severe COVID-19 patients were generated. CellPhoneDB was used to infer changes in the crosstalk between monocytes and other immune cell types. We observed DNA methylation changes in CpG sites associated with interferon-related genes and genes associated with antigen presentation, concordant with gene expression changes. These changes significantly overlapped with those occurring in bacterial sepsis, although specific DNA methylation alterations in genes specific to viral infection were also identified. We also found these alterations to comprise some of the DNA methylation changes occurring during myeloid differentiation and under the influence of inflammatory cytokines. A progression of DNA methylation alterations in relation to the Sequential Organ Failure Assessment (SOFA) score was found to be related to interferon-related genes and T-helper 1 cell cytokine production. CellPhoneDB analysis of the single-cell transcriptomes of other immune cell types suggested the existence of altered crosstalk between monocytes and other cell types like NK cells and regulatory T cells. Our findings show the occurrence of an epigenetic and transcriptional reprogramming of peripheral blood monocytes, which could be associated with the release of aberrant immature monocytes, increased systemic levels of pro-inflammatory cytokines, and changes in immune cell crosstalk in these patients. The online version contains supplementary material available at 10.1186/s13073-022-01137-4.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetics of Dendritic Cells in Tumor Immunology

  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Ballestar, Esteban|||0000-0002-1400-2440
Dendritic cells (DCs) are professional antigen-presenting cells with the distinctive property of inducing the priming and differentiation of naïve CD4+ and CD8+ T cells into helper and cytotoxic effector T cells to develop efficient tumor-immune responses. DCs display pathogenic and tumorigenic antigens on their surface through major histocompatibility complexes to directly influence the differentiation of T cells. Cells in the tumor microenvironment (TME), including cancer cells and other immune-infiltrated cells, can lead DCs to acquire an immune-tolerogenic phenotype that facilitates tumor progression. Epigenetic alterations contribute to cancer development, not only by directly affecting cancer cells, but also by their fundamental role in the differentiation of DCs that acquire a tolerogenic phenotype that, in turn, suppresses T cell-mediated responses. In this review, we focus on the epigenetic regulation of DCs that have infiltrated the TME and discuss how knowledge of the epigenetic control of DCs can be used to improve DC-based vaccines for cancer immunotherapy
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

How lineage tracing studies can unveil tumor heterogeneity in breast cancer

  • Vinuesa Pitarch, Elena|||0000-0002-3989-2494
  • Ortega Álvarez, Daniel|||0000-0002-0471-3775
  • Rodilla, Verónica|||0000-0003-0512-4179
Lineage tracing studies have become a well-suited approach to reveal cellular hierarchies and tumor heterogeneity. Cellular heterogeneity, particularly in breast cancer, is still one of the main concerns regarding tumor progression and resistance to anti-cancer therapies. Here, we review the current knowledge about lineage tracing analyses that have contributed to an improved comprehension of the complexity of mammary tumors, highlighting how targeting different mammary epithelial cells and tracing their progeny can be useful to explore the intra- and inter-heterogeneity observed in breast cancer. In addition, we examine the strategies used to identify the cell of origin in different breast cancer subtypes and summarize how cellular plasticity plays an important role during tumorigenesis. Finally, we evaluate the clinical implications of lineage tracing studies and the challenges remaining to address tumor heterogeneity in breast cancer
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Coordinated glucocorticoid receptor and MAFB action induces tolerogenesis and epigenome remodeling in dendritic cells

  • Morante-Palacios, Octavio|||0000-0002-6435-2756
  • Ciudad, Laura|||0000-0002-5219-6792
  • Micheroli, Raphael|||0000-0002-8918-7304
  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Li, Tianlu|||0000-0001-7152-4870
  • Barbisan, Gisela
  • Houtman, Miranda
  • Edalat, Sam G.
  • Frank-Bertoncelj, Mojca|||0000-0002-7257-2468
  • Ospelt, Caroline|||0000-0002-9151-4650
  • Ballestar, Esteban|||0000-0002-1400-2440
Glucocorticoids (GCs) exert potent anti-inflammatory effects in immune cells through the glucocorticoid receptor (GR). Dendritic cells (DCs), central actors for coordinating immune responses, acquire tolerogenic properties in response to GCs. Tolerogenic DCs (tolDCs) have emerged as a potential treatment for various inflammatory diseases. To date, the underlying cell type-specific regulatory mechanisms orchestrating GC-mediated acquisition of immunosuppressive properties remain poorly understood. In this study, we investigated the transcriptomic and epigenomic remodeling associated with differentiation to DCs in the presence of GCs. Our analysis demonstrates a major role of MAFB in this process, in synergy with GR. GR and MAFB both interact with methylcytosine dioxygenase TET2 and bind to genomic loci that undergo specific demethylation in tolDCs. We also show that the role of MAFB is more extensive, binding to thousands of genomic loci in tolDCs. Finally, MAFB knockdown erases the tolerogenic properties of tolDCs and reverts the specific DNA demethylation and gene upregulation. The preeminent role of MAFB is also demonstrated in vivo for myeloid cells from synovium in rheumatoid arthritis following GC treatment. Our results imply that, once directly activated by GR, MAFB plays a critical role in orchestrating the epigenomic and transcriptomic remodeling that define the tolerogenic phenotype.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

JAK2-STAT Epigenetically Regulates Tolerized Genes in Monocytes in the First Encounter With Gram-Negative Bacterial Endotoxins in Sepsis

  • Morante-Palacios, Octavio|||0000-0002-6435-2756
  • Lorente-Sorolla, Clara|||0000-0003-0404-9453
  • Ciudad, Laura|||0000-0002-5219-6792
  • Calafell-Segura, Josep|||0000-0002-0173-8221
  • Garcia-Gomez, Antonio
  • Català-Moll, Francesc|||0000-0002-2354-8648
  • Ruiz-Sanmartín, Adolfo|||0000-0001-5587-5419
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Ferrer, Ricard|||0000-0002-4859-4747
  • Ruiz-Rodriguez, Juan Carlos|||0000-0001-7392-8617
  • Álvarez-Errico, Damiana|||0000-0002-7921-5164
  • Ballestar, Esteban|||0000-0002-1400-2440
Microbial challenges, such as widespread bacterial infection in sepsis, induce endotoxin tolerance, a state of hyporesponsiveness to subsequent infections. The participation of DNA methylation in this process is poorly known. In this study, we perform integrated analysis of DNA methylation and transcriptional changes following in vitro exposure to gram-negative bacterial lipopolysaccharide, together with analysis of ex vivo monocytes from septic patients. We identify TET2-mediated demethylation and transcriptional activation of inflammation-related genes that is specific to toll-like receptor stimulation. Changes also involve phosphorylation of STAT1, STAT3 and STAT5, elements of the JAK2 pathway. JAK2 pathway inhibition impairs the activation of tolerized genes on the first encounter with lipopolysaccharide. We then confirm the implication of the JAK2-STAT pathway in the aberrant DNA methylome of patients with sepsis caused by gram-negative bacteria. Finally, JAK2 inhibition in monocytes partially recapitulates the expression changes produced in the immunosuppressive cellular state acquired by monocytes from gram-negative sepsis, as described by single cell-RNA-sequencing. Our study evidences both the crucial role the JAK2-STAT pathway in epigenetic regulation and initial response of the tolerized genes to gram-negative bacterial endotoxins and provides a pharmacological target to prevent exacerbated responses.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Vitamin D receptor, STAT3, and TET2 cooperate to establish tolerogenesis

  • Català-Moll, Francesc|||0000-0002-2354-8648
  • Ferreté-Bonastre, Anna G|||0000-0003-3327-6129
  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Morante-Palacios, Octavio|||0000-0002-6435-2756
  • Ciudad, Laura|||0000-0002-5219-6792
  • Barberà, Laura|||0000-0002-0883-657X
  • Fondelli, Federico|||0000-0002-6875-4744
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Li, Tianlu|||0000-0001-7152-4870
  • Ballestar, Esteban|||0000-0002-1400-2440
The active form of vitamin D, 1,25-dihydroxyvitamin D3, induces a stable tolerogenic phenotype in dendritic cells (DCs). This process involves the vitamin D receptor (VDR), which translocates to the nucleus, binds its cognate genomic sites, and promotes epigenetic and transcriptional remodeling. In this study, we report the occurrence of vitamin D-specific DNA demethylation and transcriptional activation at VDR binding sites associated with the acquisition of tolerogenesis in vitro. Differentiation to tolerogenic DCs associates with activation of the IL-6-JAK-STAT3 pathway. We show that JAK2-mediated STAT3 phosphorylation is specific to vitamin D stimulation. VDR and the phosphorylated form of STAT3 interact with each other to form a complex with methylcytosine dioxygenase TET2. Most importantly, pharmacological inhibition of JAK2 reverts vitamin D-induced tolerogenic properties of DCs. This interplay among VDR, STAT3, and TET2 opens up possibilities for modulating DC immunogenic properties in clinics.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses

  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Arutyunyan, Anna
  • Bonder, Marc Jan
  • Del Pino Molina, Lucía|||0000-0003-2392-097X
  • Clark, Stephen J.|||0000-0002-6183-491X
  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Garcia-Alonso, Luz|||0000-0002-7863-9619
  • Handfield, Louis-François
  • Ciudad, Laura|||0000-0002-5219-6792
  • Andrés-León, Eduardo|||0000-0002-0621-9914
  • Krueger, Felix|||0000-0002-5513-3324
  • Català-Moll, Francesc|||0000-0002-2354-8648
  • Rodríguez-Cortez, Virginia C.
  • Polanski, Krzysztof
  • Mamanova, Lira
  • van Dongen, Stijn
  • Kiselev, Vladimir Yu
  • Martínez-Saavedra, María T.|||0000-0001-8579-226X
  • Heyn, Holger|||0000-0002-3276-1889
  • Martín, Javier|||0000-0002-2202-0622
  • Warnatz, Klaus|||0000-0002-1172-865X
  • López Granados, Eduardo
  • Rodríguez-Gallego, Carlos|||0000-0002-4344-8644
  • Stegle, Oliver|||0000-0002-8818-7193
  • Kelsey, Gavin|||0000-0002-9762-5634
  • Vento Tormo, Roser|||0000-0002-9870-8474
  • Ballestar, Esteban|||0000-0002-1400-2440
Common variable immunodeficiency (CVID), the most prevalent symptomatic primary immunodeficiency, displays impaired terminal B-cell differentiation and defective antibody responses. Incomplete genetic penetrance and ample phenotypic expressivity in CVID suggest the participation of additional pathogenic mechanisms. Monozygotic (MZ) twins discordant for CVID are uniquely valuable for studying the contribution of epigenetics to the disease. Here, we generate a single-cell epigenomics and transcriptomics census of naïve-to-memory B cell differentiation in a CVID-discordant MZ twin pair. Our analysis identifies DNA methylation, chromatin accessibility and transcriptional defects in memory B-cells mirroring defective cell-cell communication upon activation. These findings are validated in a cohort of CVID patients and healthy donors. Our findings provide a comprehensive multi-omics map of alterations in naïve-to-memory B-cell transition in CVID and indicate links between the epigenome and immune cell cross-talk. Our resource, publicly available at the Human Cell Atlas, gives insight into future diagnosis and treatments of CVID patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis

  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ciudad, Laura|||0000-0002-5219-6792
  • Ramírez, Julio
  • Celis, Raquel|||0000-0002-5096-4532
  • Azuaga, Ana Belén
  • Cuervo, Andrea
  • Graell, Eduard|||0000-0002-4210-2721
  • Pérez-García, Carolina|||0000-0002-6695-6406
  • Diaz-Torne, Cesar|||0000-0001-6275-7699
  • Salvador, Georgina
  • Gómez-Puerta, Jose A.|||0000-0001-8177-702X
  • Haro, Isabel|||0000-0001-8677-2340
  • Sanmartí, Raimon|||0000-0002-8864-3806
  • Cañete, Juan D.|||0000-0003-2606-0573
  • Ballestar, Esteban|||0000-0002-1400-2440
Identifying predictive biomarkers at early stages of inflammatory arthritis is crucial for starting appropriate therapies to avoid poor outcomes. Monocytes (MOs) and macrophages, largely associated with arthritis, are contributors and sensors of inflammation through epigenetic modifications. In this study, we investigated associations between clinical features and DNA methylation in blood and synovial fluid (SF) MOs in a prospective cohort of patients with early inflammatory arthritis. DNA methylation profiles of undifferentiated arthritis (UA) blood MOs exhibited marked alterations in comparison with those from healthy donors. We identified additional differences both in blood and SF MOs after comparing patients with UA grouped by their future outcomes, i.e., good versus poor. Patient profiles in subsequent visits revealed a reversion toward a healthy level in both groups, those requiring disease-modifying antirheumatic drugs and those who remitted spontaneously. Changes in disease activity between visits also affected DNA methylation, which was partially concomitant in the SF of UA and in blood MOs of patients with rheumatoid arthritis. Epigenetic similarities between arthritis types allow a common prediction of disease activity. Our results constitute a resource of DNA methylation-based biomarkers of poor prognosis, disease activity, and treatment efficacy for the personalized clinical management of early inflammatory arthritis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection

  • Barmada, Anis
  • Handfield, Louis-François
  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Ciudad, Laura|||0000-0002-5219-6792
  • Arutyunyan, Anna
  • Andrés-León, Eduardo|||0000-0002-0621-9914
  • Hoo, Regina
  • Porter, Tarryn|||0000-0002-6063-0659
  • Oszlanczi, Agnes
  • Richardson, Laura
  • Calero-Nieto, Fernando|||0000-0003-3358-8253
  • Wilson, Nicola K.
  • Marchese, Domenica|||0000-0002-3036-4580
  • Sancho Serra, Carmen|||0009-0004-1682-5362
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Presas Rodríguez, Sílvia|||0000-0001-8545-2476
  • Ramo-Tello, Cristina|||0000-0001-8643-5053
  • Ruiz-Sanmartin, Adolfo
  • Ferrer, Ricard|||0000-0002-4859-4747
  • Ruiz-Rodriguez, Juan Carlos|||0000-0001-7392-8617
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Munera-Campos, Monica|||0000-0002-2227-2993
  • Carrascosa, José Manuel|||0000-0003-4266-0771
  • Göttgens, Berthold|||0000-0001-6302-5705
  • Heyn, Holger|||0000-0002-3276-1889
  • Prigmore, Elena|||0000-0001-8870-0316
  • Casafont Solé, Ivette|||0000-0002-1004-300X
  • Solanich, Xavier|||0000-0002-2572-2187
  • Sánchez Cerrillo, Ildefonso
  • González-Álvaro, Isidoro
  • Raimondo, Maria Gabriella
  • Ramming, Andreas
  • Martín, Javier|||0000-0002-2202-0622
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
  • Ballestar, Esteban|||0000-0002-1400-2440
  • Vento Tormo, Roser|||0000-0002-9870-8474
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
In COVID-19, hyperinflammatory and dysregulated immune responses contribute to severity. Patients with pre-existing autoimmune conditions can therefore be at increased risk of severe COVID-19 and/or associated sequelae, yet SARS-CoV-2 infection in this group has been little studied. Here, we performed single-cell analysis of peripheral blood mononuclear cells from patients with three major autoimmune diseases (rheumatoid arthritis, psoriasis, or multiple sclerosis) during SARS-CoV-2 infection. We observed compositional differences between the autoimmune disease groups coupled with altered patterns of gene expression, transcription factor activity, and cell-cell communication that substantially shape the immune response under SARS-CoV-2 infection. While enrichment of HLA-DRlow CD14+ monocytes was observed in all three autoimmune disease groups, type-I interferon signaling as well as inflammatory T cell and monocyte responses varied widely between the three groups of patients. Our results reveal disturbed immune responses to SARS-CoV-2 in patients with pre-existing autoimmunity, highlighting important considerations for disease treatment and follow-up.